CRISPR/Cas9 from bench to bedside: what clinicians need to know before application?

0Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In October 2020, Dr. Emmanuelle Charpentier and Dr. Jennifer Doudna won the Nobel Prize in Chemistry for their pioneering work in precise genome editing using the CRISPR technology. Although CRISPR technology has developed rapidly in the last decade, there are still many uncertainties before eventual use in clinical settings. In this mini review, we summarize the current efforts in addressing the limitations of CRISPR technology and future directions.

Cite

CITATION STYLE

APA

Li, Z. Q., & Li, C. H. (2020, December 1). CRISPR/Cas9 from bench to bedside: what clinicians need to know before application? Military Medical Research. BioMed Central Ltd. https://doi.org/10.1186/s40779-020-00292-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free